HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Diseases of the Digestive System - Liver | HIV/AIDS | Infectious Diseases
What is the purpose of this trial?
This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted an HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group.
- Ages18 years and older
- Trial withJohns Hopkins University
- Start Date07/22/2019
- End Date06/30/2024
- Last Updated08/27/2021
- Study HIC#2000025220